Skip to main content

Norepinephrine infusion for prophylaxis against spinal-induced hypotension in elderly patients undergoing hip surgery: a randomized controlled comparison of two doses

Journal
BMC anesthesiology (Q1)
Published
20 August 2026
Study design
Randomized controlled trial
Evidence level
Level 1, High (CEBM 1b)
Authors
Michael Wahib, Maha Mostafa, Ahmed Hasanin, Eman Alaa Alashmawy, Mahmoud Mustafa, Mai Y Taha, et al.
PMID
42675458
DOI
10.1186/s12871-026-04174-3

Why clinicians should know about it

  • Picked for Pharmacology (medical) (paper of the day, 6 September 2026): Dose comparison of norepinephrine infusion rates in elderly
  • Picked for Anesthesiology and Pain Medicine (top studies of the week, 6 September 2026): Norepinephrine infusion for spinal‑induced hypotension in elderly hip surgery
  • Picked for Surgery (top studies of the week, 6 September 2026): Norepinephrine infusion, non-inferiority RCT in hip surgery

Abstract

BACKGROUND: We aimed to compare the hemodynamic response to two norepinephrine infusion rates for prophylaxis against post-spinal hypotension in elderly population undergoing hip surgery. METHODS: This randomized non-inferiority clinical trial included elderly patients scheduled for hip surgery under spinal anesthesia. Patients received norepinephrine infusion at a rate of 0.1 mcg/kg/min (0.1-mcg group) or 0.07 mcg/kg/min (0.07-mcg group) after spinal anesthesia. Intraoperative mean arterial pressure (MAP) and heart rate were recorded every 2 min for 46 min after spinal anesthesia. The primary outcome was the noninferiority comparison between the two groups regarding the average MAP readings. Non-inferiority was declared if the average post-spinal MAP in the 0.07-mcg group was within 8 mmHg of the 0.1-mcg group. Secondary outcomes were incidence of post-spinal hypotension (MAP < 70% of baseline or < 65 mmHg), bradycardia, and hypertension. The secondary outcomes were assessed for superiority. RESULTS: Eighty-four patients were analyzed. The average intraoperative MAP was 87.9 ± 9.5 mmHg in the 0.1-mcg group and 84.5 ± 8.5 mmHg in the 0.07-mcg group, with a mean difference of -3.5 mmHg (95% confidence interval: -7.4 to 0.4 mmHg) and the lower bound of the 95% confidence interval did not cross the prespecified non-inferiority margin. The incidence of hypotension, hypertension, and bradycardia was comparable between the two groups. CONCLUSION: In elderly patients undergoing hip surgery under spinal anesthesia, a norepinephrine infusion rate of 0.07 mcg/kg/min was not inferior to 0.1 mcg/kg/min in maintaining post-spinal MAP. Both infusion rates had comparable profile regarding adverse events, namely reactive hypertension and bradycardia. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT07077265. URL: https://www. CLINICALTRIALS: gov/study/NCT07077265?term=NCT07077265&rank=1 .

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.